Paper8555935
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Spitzer WO and 4 others. BMJ, 1996. Cited by 467 papers, by iCite.
Cite this record
ConductScience Library. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. Papers, record 8555935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8555935
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.
- PubMed
- Publication types
- Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Contraceptives, Oral, Combined | Major topic |
| Contraceptives, Oral, Synthetic | Major topic |
| Thromboembolism | Major topic |
| Adolescent | |
| Adult | |
| Case-Control Studies | |
| Desogestrel | |
| Female | |
| Germany | |
| Humans | |
| Norpregnenes | |
| Odds Ratio | |
| Risk Factors | |
| United Kingdom |
Source PubMed
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 8555921 | Third generation oral contraception and venous thromboembolism. | https://conductscience.org/library/papers/8555921 | PubMed |
| Comment in | 8595302 | Third generation oral contraceptives. Study's results do not apply to norgestimate. | https://conductscience.org/library/papers/8595302 | PubMed |
| Comment in | 8595303 | Third generation oral contraceptives. Full description of controls is needed in study. | https://conductscience.org/library/papers/8595303 | PubMed |
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4825599 | Proportion of disease caused or prevented by a given exposure, trait or intervention. | Am J Epidemiol | 1974 | https://conductscience.org/library/papers/4825599 | PubMed |
| 2 | 5160433 | Attributable risk percent in case-control studies. | Br J Prev Soc Med | 1971 | https://conductscience.org/library/papers/5160433 | PubMed |
| 3 | 7022208 | Oral contraceptives and cardiovascular disease (first of two parts). | N Engl J Med | 1981 | https://conductscience.org/library/papers/7022208 | PubMed |
| 4 | 6403700 | Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol. | J Reprod Med | 1983 | https://conductscience.org/library/papers/6403700 | PubMed |
| 5 | 3208516 | Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 75 micrograms gestodene. | Contraception | 1988 | https://conductscience.org/library/papers/3208516 | PubMed |
| 6 | 2527727 | Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptives. | Contraception | 1989 | https://conductscience.org/library/papers/2527727 | PubMed |
| 7 | 8341154 | Benefits and risks of combined oral contraceptives. | Methods Inf Med | 1993 | https://conductscience.org/library/papers/8341154 | PubMed |
Cited by79
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 467 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41048432 | Chapter 3. Impact of estrogens on hemostasis. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41048432 | PubMed |
| 40831646 | Studying the Effects of Oral Contraceptives on Coagulation Using a Mathematical Modeling Approach. | Math Model Womens Health (2024) | 2024 | https://conductscience.org/library/papers/40831646 | PubMed |
| 39358019 | Beyond Birth Control: The Neuroscience of Hormonal Contraceptives. | J Neurosci | 2024 | https://conductscience.org/library/papers/39358019 | PubMed |
| 39220361 | Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39220361 | PubMed |
| 39130626 | Gestodene, a novel positive allosteric modulator of PAR1, enhances PAR1-mediated human platelet aggregation. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39130626 | PubMed |
| 38717871 | Testosterone Therapy Does Not Affect Coagulation in Male Hypogonadism: A Longitudinal Study Based on Thrombin Generation. | J Clin Endocrinol Metab | 2024 | https://conductscience.org/library/papers/38717871 | PubMed |
| 37822706 | Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays. | Res Pract Thromb Haemost | 2023 | https://conductscience.org/library/papers/37822706 | PubMed |
| 37204712 | Evaluation of Activated Protein C Resistance Using Thrombin Generation Test. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/37204712 | PubMed |
| 37075041 | High risk oral contraceptive hormones do not directly enhance endothelial cell procoagulant activity in vitro. | PLoS One | 2023 | https://conductscience.org/library/papers/37075041 | PubMed |
| 36099501 | Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone. | J Clin Endocrinol Metab | 2022 | https://conductscience.org/library/papers/36099501 | PubMed |
| 34956081 | Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34956081 | PubMed |
| 32551357 | The French pill scare and the reshaping of social inequalities in access to medical contraceptives. | SSM Popul Health | 2020 | https://conductscience.org/library/papers/32551357 | PubMed |
| 30519125 | Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives? | Open Access J Contracept | 2018 | https://conductscience.org/library/papers/30519125 | PubMed |
| 30359453 | The effects of oral contraceptive usage on thrombin generation and activated protein C resistance in Saudi women, with a possible impact of the body mass index. | PLoS One | 2018 | https://conductscience.org/library/papers/30359453 | PubMed |
| 29998477 | The incidence and prognosis of thromboembolism associated with oral contraceptives: Age-dependent difference in Japanese population. | J Obstet Gynaecol Res | 2018 | https://conductscience.org/library/papers/29998477 | PubMed |
| 29388678 | A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. | Int J Gynaecol Obstet | 2018 | https://conductscience.org/library/papers/29388678 | PubMed |
| 27747613 | Impact of the 2013 French Pill Crisis on Women's Behaviour Regarding Contraception. | Drugs Real World Outcomes | 2015 | https://conductscience.org/library/papers/27747613 | PubMed |
| 27582790 | Contraception in women with medical problems. | Obstet Med | 2008 | https://conductscience.org/library/papers/27582790 | PubMed |
| 27153743 | Progestin-only contraception and thromboembolism: A systematic review. | Contraception | 2016 | https://conductscience.org/library/papers/27153743 | PubMed |
| 26696010 | Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use. | Blood | 2016 | https://conductscience.org/library/papers/26696010 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8555935
GET https://conductscience.org/api/papers/v1/8555935/cited_by?page=2